Forcina A
607  Ergebnisse:
Personensuche X
?
1

A phase II, open‐label, multicenter study of capivasertib, ..:

Hodson, D. ; Shouse, G. ; Shin, H....
Hematological Oncology.  41 (2023)  S2 - p. 562-564 , 2023
 
?
2

HIGH COMPLETE RESPONSE RATE WITH TNB‐486, A NOVEL CD19XCD3 ..:

Cho, S. ; Nair, R. ; Jacobs, R....
Hematological Oncology.  41 (2023)  S2 - p. 127-129 , 2023
 
?
3

Economic-Comparative Study for Carbon Neutrality During Shi..:

Di Micco, S. ; Silvestri, L. ; Forcina, A...
Journal of Physics: Conference Series.  2385 (2022)  1 - p. 012049 , 2022
 
?
4

Power-to-hydrogen pathway in the transport sector: How to a..:

Silvestri, L. ; Di Micco, S. ; Forcina, A...
Energy Conversion and Management.  252 (2022)  - p. 115067 , 2022
 
?
5

Analyzing the levelized cost of hydrogen in refueling stati..:

Minutillo, M. ; Perna, A. ; Forcina, A...
International Journal of Hydrogen Energy.  46 (2021)  26 - p. 13667-13677 , 2021
 
?
6

PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF ..:

Jaeger, U. ; McGuirk, J. ; Worel, N....
Hematological Oncology.  37 (2019)  S2 - p. 560-560 , 2019
 
?
7

INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH REL..:

Jaeger, U. ; Tam, C. ; Borchmann, P....
Hematological Oncology.  37 (2019)  S2 - p. 505-507 , 2019
 
?
9

IFM target 2.0: an innovative method to define reliability ..:

Di Bona, G. ; Falcone, D. ; Silvestri, A..
The International Journal of Advanced Manufacturing Technology.  95 (2017)  9-12 - p. 3349-3367 , 2017
 
?
11

Control of infectious mortality due to carbapenemase-produc..:

Forcina, A ; Baldan, R ; Marasco, V...
Bone Marrow Transplantation.  52 (2016)  1 - p. 114-119 , 2016
 
?
 
?
 
?
15

A class of smooth models satisfying marginal and context sp..:

Colombi, R. ; Forcina, A.
Journal of Multivariate Analysis.  126 (2014)  - p. 75-85 , 2014
 
1-15